GSK1265744 rapidly suppresses HIV and appears safe at selected dose
CCR5 inhibitor cenicriviroc shows good activity against HIV; new formulation may reduce dropouts
Long-acting antiretrovirals may improve survival for people with poor adherence
New integrase inhibitor GSK1265744 safe and well tolerated in eight studies
Stribild is effective and well tolerated in older people with HIV
Single-tablet regimen improves antiretroviral adherence and reduces hospitalisation
Switching from Atripla to Eviplera reduces central nervous system side-effects
Raltegravir appears safe for mothers and babies during pregnancy
Novel NNRTI AIC292 works well against drug-resistant HIV
